BioSig Technologies, Inc. BSGM
Set alert
6.10 0.00 0.00%
At close · Sep 11
4.36 Day range 6.12
4.36 52-week range 6.12
- Open
- 4.44
- Prev close
- 6.10
- Mkt cap
- 191.13M
- Vol
- 3.01M
- Avg vol
- 918.25K
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.36
- High
- 6.12
- Forward P/E
- -1.95
- Beta
- 0.35
- Short ratio
- 0.56
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.38
- 200-d avg
- 0.937115
- 1y target
- 2.75
3M chart
Signals (15)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Jun 11, 2024 | 2 years ago |
| RSI: Oversold | Jun 11, 2024 | 2 years ago |
| SMA: Bearish | Jun 10, 2024 | 2 years ago |
| MACD: Sell Signal | Jun 7, 2024 | 2 years ago |
| RSI: Overbought | May 29, 2024 | 2 years ago |
| MACD: Buy Signal | May 20, 2024 | 2 years ago |
| SMA: Bullish | May 13, 2024 | 2 years ago |
| SMA: Bearish | May 8, 2024 | 2 years ago |
| MACD: Sell Signal | May 6, 2024 | 2 years ago |
| MACD: Buy Signal | May 1, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 25, 2024 | 2 years ago |
| SMA: Bullish | Apr 8, 2024 | 2 years ago |
| RSI: Overbought | Apr 8, 2024 | 2 years ago |
| SMA: Bullish | Mar 27, 2024 | 2 years ago |
| RSI: Oversold | Mar 12, 2024 | 2 years ago |
Key statistics
- Market cap
- 25.51M
- Enterprise value
- 27.93M
- Trailing P/E
- 0.00
- Forward P/E
- -1.95
- PEG ratio
- 0.00
- Price / sales
- 637.69
- Price / book
- 0.00
- EPS (TTM)
- -1.34
- Beta
- 0.35
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 40.00K
- Revenue growth
- 0.00%
- Free cash flow
- -4.40M
- Total cash
- 2.10M
- Total debt
- 282.00K
- Return on equity
- -6342.03%
- Shares outstanding
- 17.23M
- Short % of float
- 1.27%
- 50-day average
- 1.38
- 200-day average
- 0.937115
Analyst view
Consensus: none
Price target (mean) 2.75
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.17.
Financials — quick view
BSGM Revenue — quarterly 0
BSGM Net income — quarterly -20.37M
BSGM EPS — quarterly -0.74
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 5, 2024 | Ascendiant Capital | main | Buy | Buy |
About BioSig Technologies, Inc.
BioSig Technologies, Inc., a medical technology company, focuses on deciphering the body's electrical signals starting with heart rhythms. It delivers unprecedented cardiac signal clarity, ending the reliance on mixed signals and reading between the lines. The company's product, the PURE EP Platform, provides real-time signal visualization allowing physicians to perform targeted cardiac ablation procedures with increased procedural efficiency and efficacy. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- biosig.com
News
- Streamex Corp., NASDAQ: STEX & Simplify Asset Management $10 billion USD AUM ETF Manager Announces Letter of Intent Pursuing a Strategic Partnership to Drive ETF Innovation through Integration of Tokenized Gold Yield Assets and Tokenization of Existing ETFs
- Streamex Corp., NASDAQ: STEX & Simplify Asset Management $10 billion USD AUM ETF Manager Announces Letter of Intent Pursuing a Strategic Partnership to Drive ETF Innovation through Integration of Tokenized Gold Yield Assets and Tokenization of Existing ETFs
- BioSig Technologies, Inc. Announces Corporate Rebrand to Streamex Corp.
- BioSig Technologies Supplements Clarification on Recent Schedule 14A Filing. Closing of Merger with Streamex Exchange Corporation Not Affected
- Streamex (BSGM) to Participate in the 5th Annual Needham Virtual Crypto 1x1 Conference on September 4th
- BioSig Technologies, Inc. & Streamex Announce Closing of $15 Million Public Offering
- BioSig Technologies Inc. Announces Pricing of $15 Million Public Offering
- BioSig Technologies Inc. Announces Proposed Public Offering
- BIOSIG TECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of BioSig Technologies, Inc. - BSGM
- Here's 1 New Billion-Dollar Reason to Buy Solana And Never Look Back
Your note
Sign in to keep a note on BSGM — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ABELMAN STEVEN E. J.D. | Director | Stock Award(Grant) | Jul 25, 2024 | 80,000 |
| AMATO ANTHONY N. | Chief Executive Officer | Stock Award(Grant) | Sep 10, 2024 | 2,108,200 |
| BAER CHRIS | Director | Stock Award(Grant) | Jul 25, 2024 | 80,000 |
| BARRY JAMES J | Director | Stock Award(Grant) | Aug 14, 2023 | 71,249 |
| BROWNE DONALD F. | Director | Stock Award(Grant) | Jul 25, 2024 | 80,000 |
| FLEMING GRAY | Officer | Stock Award(Grant) | Nov 29, 2023 | 463,556 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Steward Partners Investment Advisory, LLC | 0.01% | 900 | 1.33K | Jun 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Northern Small Cap Core Fund | 0.00% | 1 | 1 | Sep 29, 2024 |